TY - JOUR
T1 - Lowering blood pressure in primary care in Vienna (LOW-BP-VIENNA)
T2 - A cluster-randomized trial
AU - Rohla, Miklos
AU - Tscharre, Maximilian
AU - Huber, Kurt
AU - Weiss, Thomas W
N1 - Funding Information:
Funding The study was supported by an unrestricted educational grant from Daiichi Sankyo and Medtronic, by the Werner-Klein Award of the Austrian Society of Hypertension and by the Association for the Promotion of Research in Atherosclerosis, Thrombosis and Vascular Biology.
Funding Information:
We would like to thank all participating physicians for their efforts and dedicated work. The study was supported by an unrestricted educational grant from Daiichi Sankyo and Medtronic, by the Werner-Klein Award of the Austrian Society of Hypertension and by the Association for the Promotion of Research in Atherosclerosis, Thrombosis and Vascular Biology. M. Rohla received advisory fees from Daiichi Sankyo and Novartis, and lecturing fees from Biotronik and Takeda Pharma, all outside the submitted work. K. Huber received lecturing fees and advisory honoraria from Boehringer Ingelheim, Pfizer/BMS, Bayer, Daiichi Sankyo, Sanofi-Aventis, AstraZeneca, and Eli Lilly. T.W. Weiss received lecturing fees and advisory fees from Daiichi Sankyo, Boehringer Ingelheim and Pfizer/BMS. M. Tscharre declares that he has no competing interests.
Publisher Copyright:
© 2018, The Author(s).
PY - 2018/12/1
Y1 - 2018/12/1
N2 - BACKGROUND: In Austria only 41% of patients with treated hypertension (HTN) have their blood pressure (BP) controlled. This study investigated a strategy to improve BP control in primary care.METHODS: General practitioners (GPs) were randomized to interventional care vs. standard care and included patients with uncontrolled office BP > 140/90 mm Hg. In interventional care, antihypertensive therapy was up-titrated using a single pill combination (olmesartan, amlodipine and/or hydrochlorothiazde) in 4‑week intervals. In standard care, physicians were encouraged to treat according to the 2013 European Society of Cardiology guidelines for the management of arterial hypertension. The primary endpoint was the proportion of patients with controlled office BP < 140/90 mm Hg at 6 months. The main secondary endpoint was the improvement in 24 h ambulatory BP (ABPM, Clinicaltrials.gov NCT02377661).RESULTS: Between 2015-2017, 20 GPs contributed to patient recruitment. The trial was discontinued due to slow recruitment after inclusion of 139 eligible patients, 54 of whom were included in the interventional group. A significantly larger proportion of patients in interventional vs. standard care achieved the office BP target (67% ± 26% vs. 39% ± 29%, respectively, mean difference -27.9%, 95% confidence interval CI -54.0%; -1.7%, p = 0.038). The proportion of patients with controlled 24 h ABPM (<130/80 mm Hg) was similar between groups (49% ± 33% vs. 40% ± 34%, respectively, mean difference -8.8%, 95% CI -40.7%; 23.1%, p = 0.57). At baseline, pretreated patients received an average of 1.5 ± 0.8 vs. 1.7 ± 0.9 antihypertensive prescriptions. At 6 months, the respective BP reductions were achieved with 1.2 ± 0.5 prescriptions in interventional vs. 2.0 ± 1.0 in standard care (p < 0.01).CONCLUSION: In both groups statistically and clinically significant BP reductions were observed after 6 months. In the interventional care group, a larger proportion of patients achieved the office BP target compared to standard care. The 24 h ambulatory blood pressure levels were controlled in 44% of patients at 6 months, without significant differences between groups. The respective BP reductions were achieved with a significantly lower medication burden in interventional care.
AB - BACKGROUND: In Austria only 41% of patients with treated hypertension (HTN) have their blood pressure (BP) controlled. This study investigated a strategy to improve BP control in primary care.METHODS: General practitioners (GPs) were randomized to interventional care vs. standard care and included patients with uncontrolled office BP > 140/90 mm Hg. In interventional care, antihypertensive therapy was up-titrated using a single pill combination (olmesartan, amlodipine and/or hydrochlorothiazde) in 4‑week intervals. In standard care, physicians were encouraged to treat according to the 2013 European Society of Cardiology guidelines for the management of arterial hypertension. The primary endpoint was the proportion of patients with controlled office BP < 140/90 mm Hg at 6 months. The main secondary endpoint was the improvement in 24 h ambulatory BP (ABPM, Clinicaltrials.gov NCT02377661).RESULTS: Between 2015-2017, 20 GPs contributed to patient recruitment. The trial was discontinued due to slow recruitment after inclusion of 139 eligible patients, 54 of whom were included in the interventional group. A significantly larger proportion of patients in interventional vs. standard care achieved the office BP target (67% ± 26% vs. 39% ± 29%, respectively, mean difference -27.9%, 95% confidence interval CI -54.0%; -1.7%, p = 0.038). The proportion of patients with controlled 24 h ABPM (<130/80 mm Hg) was similar between groups (49% ± 33% vs. 40% ± 34%, respectively, mean difference -8.8%, 95% CI -40.7%; 23.1%, p = 0.57). At baseline, pretreated patients received an average of 1.5 ± 0.8 vs. 1.7 ± 0.9 antihypertensive prescriptions. At 6 months, the respective BP reductions were achieved with 1.2 ± 0.5 prescriptions in interventional vs. 2.0 ± 1.0 in standard care (p < 0.01).CONCLUSION: In both groups statistically and clinically significant BP reductions were observed after 6 months. In the interventional care group, a larger proportion of patients achieved the office BP target compared to standard care. The 24 h ambulatory blood pressure levels were controlled in 44% of patients at 6 months, without significant differences between groups. The respective BP reductions were achieved with a significantly lower medication burden in interventional care.
KW - Adolescent
KW - Adult
KW - Aged
KW - Aged, 80 and over
KW - Antihypertensive Agents
KW - Austria
KW - Blood Pressure
KW - Blood Pressure Monitoring, Ambulatory
KW - Female
KW - Humans
KW - Hypertension
KW - Middle Aged
KW - Primary Health Care
KW - Prospective Studies
KW - Young Adult
KW - Single pill combination drugs
KW - Hypertension control
KW - Ambulatory blood pressure measurement
KW - Disease management programs
KW - Arterial hypertension
UR - http://www.scopus.com/inward/record.url?scp=85051845081&partnerID=8YFLogxK
U2 - 10.1007/s00508-018-1374-4
DO - 10.1007/s00508-018-1374-4
M3 - Journal article
C2 - 30112584
SN - 0043-5325
VL - 130
SP - 698
EP - 706
JO - Wiener Klinische Wochenschrift
JF - Wiener Klinische Wochenschrift
IS - 23-24
ER -